Skip to contentT
Trulieve Cannabis Corp.
T
TRLVTrulieve Cannabis Corp. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$293.15M$293.15Mderived−2.7% vs Q4 2024 Net Income-$37.73M-$37.73MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Trulieve Cannabis Corp. · CIK 1754195 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$175,165,000−6.3% Operating Incomederived$15,297,000+1,069.5% Operating Cash Flowderived$59,216,000+93.0% Free Cash Flowderived$55,805,000N/M Margins · derivedGross margin59.8%−2.3 pt vs Q4 2024
Operating margin5.2%+4.8 pt vs Q4 2024
Net margin-12.9%+6.1 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 26, 2026 · 57 d after period end